Literature DB >> 12692102

Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?

Garth H Rauscher1, Dale P Sandler, Charles Poole, James Pankow, David Shore, Clara D Bloomfield, Andrew F Olshan.   

Abstract

The risk factors for adult acute leukemia incidence have been difficult to establish. Family history of cancer might interact with environmental exposures to produce associations that are otherwise difficult to detect. In addition to family history of leukemia or other hematopoietic cancers, family history of breast cancer could be a marker of susceptibility, because leukemia and breast cancer are known to cluster in families that have specific germ-line mutations. In a population-based case control study of 779 incident adult acute leukemia patients and 625 controls, we estimated the relative risk for exposed individuals with a family history compared with unexposed individuals without a family history (RR(11)), along with a measure of interdependence, the interaction contrast ratio. Combined with a family history of breast cancer, ever-smoking [RR(11) = 2.4, 95% confidence interval (CI): 1.2-4.8], general solvent exposure (RR(11) = 1.9, 95% CI: 1.1-3.4), aromatic hydrocarbon exposure (RR(11) = 3.8, 95% CI: 1.1-14), and diagnostic ionizing radiation exposure (RR(11) = 2.1, 95% CI: 1.2-3.8) were all associated with increased incidence. Furthermore, there was no increased incidence associated with any of these exposures in the absence of a family history of breast cancer and no increased incidence for family history of breast cancer in the absence of exposures. The pattern of relative risks strongly suggested synergy across exposures. Family history of breast cancer might be a marker of susceptibility to a range of leukemia risk factors, whose effects are generally weak or nonexistent when considered alone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692102

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  6 in total

1.  Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.

Authors:  Deirdre A Hill; Ethel Gilbert; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars Van't Veer; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle E Curtis; James M Allan; John D Boice; Lois B Travis
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

Review 2.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

3.  Incidence of acute myeloid leukemia after breast cancer.

Authors:  Caterina Giovanna Valentini; Luana Fianchi; Maria Teresa Voso; Morena Caira; Giuseppe Leone; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-22       Impact factor: 2.576

4.  Measuring additive interaction using odds ratios.

Authors:  Linda Kalilani; Julius Atashili
Journal:  Epidemiol Perspect Innov       Date:  2006-04-18

Review 5.  Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?

Authors:  Alberto Fresa; Simona Sica
Journal:  Hered Cancer Clin Pract       Date:  2021-04-01       Impact factor: 2.857

Review 6.  The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers.

Authors:  Bernard Friedenson
Journal:  BMC Cancer       Date:  2007-08-06       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.